EGFR transactivation is involved in TNF-α-induced expression of thymic stromal lymphopoietin in human keratinocyte cell line

Background: Thymic stromal lymphopoietin (TSLP) is an epithelial cell-derived cytokine involved in the pathology of inflammatory skin diseases, such as atopic dermatitis and psoriasis. Tumor necrosis factor (TNF)-alpha, a key cytokine in inflammatory skin diseases, is a known TSLP inducer. TNF-alpha activates NF-kappa B and induces transactivation of epidermal growth factor receptor (EGFR) in epithelial cells. However, the detailed mechanism of TSLP induction by TNF-alpha has remained unclear. Objective: We investigated the involvement of TNF-alpha-induced EGFR transactivation in TSLP expression. Methods: HaCaT cells were stimulated with TNF-alpha or EGF in the presence or absence of an EGFR kinase inhibitor or other signaling inhibitors. The expression of TSLP mRNA was analyzed by RT-PCR and the phosphorylation level of signal proteins was analyzed by western blot. TSLP promoter and NF-kappa B transcription activities were analyzed by luciferase assay. Results: TNF-alpha-induced TSLP expression was inhibited by the EGFR kinase inhibitor AG1478. While TSLP expression was induced by EGF, it was inhibited by the MEK inhibitor, U0126. Inhibitors of p38 and ADAM proteases suppressed the TNF-alpha-induced TSLP expression and EGFR phosphorylation, but not the EGF-induced expression. Conclusion: TNF-alpha-induced EGFR transactivation results in TSLP induction through ERK activation. The activation of p38 and ADAM proteases mediates TNF-alpha-induced EGFR phosphorylation. These findings suggested that the TNF-alpha-induced EGFR transactivation pathway could be a target for the treatment of inflammatory skin diseases. (C) 2017 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.